Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00227721
Status:
COMPLETED
Last Update Posted:
2020-12-02
First Post:
2005-09-26
Brief Title:
Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer
Sponsor:
Robert Morris
Organization:
Barbara Ann Karmanos Cancer Institute
Organization Data
Organization:
Barbara Ann Karmanos Cancer Institute
Class:
OTHER
Study ID:
CDR0000445432
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Robert Morris
Lead Sponsor Class:
OTHER
Responsible Party:
Robert Morris
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Barbara Ann Karmanos Cancer Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |